[#item_full_content] Anebulo Pharmaceuticals has started dosing participants in its Phase I SAD trial of IV selonabant, an antidote targeting acute cannabis-induced toxicity. Read More
[#item_full_content] Anebulo Pharmaceuticals has started dosing participants in its Phase I SAD trial of IV selonabant, an antidote targeting acute cannabis-induced toxicity. Read More